Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2020
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
Paul Stockhammer, Cassandra Su Lyn Ho, Luca Hegedus, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2023
Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
Paul Stockhammer, Hannah Baumeister, Till Ploenes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2021
Impact of EBUS-TBNA in addition to [<sup>18</sup>F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Translational Oncology
|
November 20, 2021
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer
Martin Metzenmacher, Balazs Hegedüs, Jan Forster, et al.
Radiation Oncology (London, England)
|
September 16, 2021
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY
Maja Guberina, Christoph Poettgen, Martin Metzenmacher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2021
DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
Lea M Schotten, Kaid Darwiche, Michal Seweryn, et al.
Scientific Reports
|
October 20, 2022
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
Maja Guberina, Ken Herrmann, Christoph Pöttgen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 8, 2026
Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural Mesothelioma
Lukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Annals of Surgical Oncology
|
July 11, 2024
Correction: ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors
Marco Chiappetta, Filippo Lococo, Carolina Sassorossi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2020
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
Paul Stockhammer, Cassandra Su Lyn Ho, Luca Hegedus, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2023
Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
Paul Stockhammer, Hannah Baumeister, Till Ploenes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2021
Impact of EBUS-TBNA in addition to [<sup>18</sup>F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Translational Oncology
|
November 20, 2021
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer
Martin Metzenmacher, Balazs Hegedüs, Jan Forster, et al.
Radiation Oncology (London, England)
|
September 16, 2021
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY
Maja Guberina, Christoph Poettgen, Martin Metzenmacher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2021
DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
Lea M Schotten, Kaid Darwiche, Michal Seweryn, et al.
Scientific Reports
|
October 20, 2022
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
Maja Guberina, Ken Herrmann, Christoph Pöttgen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 8, 2026
Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural Mesothelioma
Lukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Annals of Surgical Oncology
|
July 11, 2024
Correction: ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors
Marco Chiappetta, Filippo Lococo, Carolina Sassorossi, et al.
Page
of 5